Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma
Completed · Phase 2
Conditions studied: Marginal Zone Lymphoma, MZL
In brief
This is a single arm study to evaluate the efficacy, safety and tolerability of zanubrutinib (BGB-3111) in participants with relapsed/refractory marginal zone lymphoma (R/R MZL).
Key facts
- Study ID
- NCT03846427
- Run by
- BeiGene
- People needed
- 68
- Starts
- 2019-02-19
- Expected to finish
- 2022-05-04
- Last updated by the study team
- 2024-10-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Research Alliance, Inc — Westbury, New York, United States
- The Charlotte Mecklenburg Hospital Authority — Charlotte, North Carolina, United States
- Canberra Hospital — Garran, Australian Capital Territory, Australia
- Concord Repatriation General Hospital — Concord, New South Wales, Australia
- The Saint George Hospital Kogarah — Kogarah, New South Wales, Australia
- Princess Alexandra Hospital — Brisbane, Queensland, Australia
- Flinders Medical Centre — Bedford PK, South Australia, Australia
- Box Hill Hospital — Box Hill, Victoria, Australia
- Monash Health — Clayton, Victoria, Australia
- Peninsula Private Hospital — Frankston, Victoria, Australia
- Peking University Third Hospital — Beijing, Beijing Municipality, China
- Henan Cancer Hospital — Zhengzhou, Henan, China
- Institute of Hematology and Hospital of Blood Disease — Tianjin, Tianjin Municipality, China
- The First Affiliated Hospital, Zhejiang University School of Medicine — Hangzhou, Zhejiang, China
- University Hospital Vinohrady Hematology Department — Prague, Czechia
- Centre de Lutte Contre Le Cancer Institut Bergonie — Bordeaux, France
- Hopital de La Conception Aphm — Marseille, France
- Hopital Saint Louis — Paris, France
- Chu Hopital Lyon Sud — PierreBenite, France
- Policlinico Sorsola Malpighi, Aou Di Bologna — Bologna, Italy
- Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda — Milan, Italy
- Universita Degli Studi Di Modena Azienda Ospedaliere Policlinco — Modena, Italy
- Azienda Ospedaliera S Maria Di Terni — Terni, Italy
- Ao Citta Della Salute E Della Scienza Di Torino Presidio O — Torino, Italy
- Auckland City Hospital — Auckland, New Zealand
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.